Company
Portfolio
Our Focus
For Patients
Contact
For Investors
Watch Commercial
Leadership
Chief Executive Officer
Co-Founder
eBioMedicine Lancet: Phase 2a Results for Topical Treatment (WST-057) that Reverses Peripheral Neuropathy and Regrows Nerves
Dec 5, 2025
What is HIV-Induced Neuropathy?
Dec 6, 2024
The Science of Sweat: Exploring Its Impact on Diabetics and Neuropathy Patients
Jul 20, 2024
